Moreover, combined quantification of LAPTM4B and LGR5 expression demonstrated superior predictive power for tumor progression compared to individual markers, underscoring the synergistic influence of heterogeneous stem‐like cell populations on patient outcomes. The gene discussed is LAPTM4B; the disease is neoplasm.